Scoring system to predict response to IFN-β in patients with multiple sclerosis

被引：0
|
作者：
机构：
来源：
Nature Reviews Neurology | 2012年 / 8卷 / 11期
关键词：
D O I：
10.1038/nrneurol.2012.216
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：594 / 594
相关论文
共 50 条
  • [41] Early benefits of neutralizing antibodies against IFN-β in multiple sclerosis
    Nature Clinical Practice Neurology, 2007, 3 (5): : 246 - 247
  • [42] Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate
    Kulakova, Olga G.
    Tsareva, Ekaterina Yu
    Lvovs, Dmitrijs
    Favorov, Alexander V.
    Boyko, Alexey N.
    Favorova, Olga O.
    PHARMACOGENOMICS, 2014, 15 (05) : 679 - 685
  • [43] Glatiramer acetate and IFN-β act on dendritic cells in multiple sclerosis
    Hussien, Y
    Sanna, A
    Söderström, M
    Link, H
    Huang, YM
    JOURNAL OF NEUROIMMUNOLOGY, 2001, 121 (1-2) : 102 - 110
  • [44] Is it time to consider rationalising IFN-β treatment in individuals with multiple sclerosis?
    Giovannoni, G
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (09): : 1234 - 1234
  • [45] Pharmacogenomics of IFN-β in multiple sclerosis: towards a personalized medicine approach
    Vosslamber, Saskia
    van Baarsen, Lisa G. M.
    Verweij, Cornelis L.
    PHARMACOGENOMICS, 2009, 10 (01) : 97 - 108
  • [46] Impaired IFN-γ production and proliferation of NK cells in Multiple Sclerosis
    Luenemann, Anna
    Tackenberg, Bjoern
    DeAngelis, Tracy
    da Silva, Rosa Barreira
    Messmer, Brady
    Vanoaica, Liliana D.
    Miller, Aaron
    Apatoff, Brian
    Lublin, Fred D.
    Luenemann, Jan D.
    Muenz, Christian
    INTERNATIONAL IMMUNOLOGY, 2011, 23 (02) : 139 - 148
  • [47] Low baseline IFN-γ response could predict hospitalization in COVID-19 patients
    Cremoni, Marion
    Allouche, Jonathan
    Graca, Daisy
    Zorzi, Kevin
    Fernandez, Celine
    Teisseyre, Maxime
    Benzaken, Sylvia
    Ruetsch-Chelli, Caroline
    Esnault, Vincent L. M.
    Dellamonica, Jean
    Carles, Michel
    Barriere, Jerome
    Ticchioni, Michel
    Brglez, Vesna
    Seitz-Polski, Barbara
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [48] Effects of IFN-β1 on tight-junctional proteins and barrier integrity induced by IFN-γ:: Role in Multiple Sclerosis
    Elrod, JW
    Long, A
    Jennings, KH
    Minagar, A
    Alexander, S
    FASEB JOURNAL, 2004, 18 (04): : A677 - A677
  • [49] Excessive Biologic Response to IFNβ Is Associated with Poor Treatment Response in Patients with Multiple Sclerosis
    Rudick, Richard A.
    Rani, M. R. Sandhya
    Xu, Yaomin
    Lee, Jar-Chi
    Na, Jie
    Shrock, Jennifer
    Josyula, Anupama
    Fisher, Elizabeth
    Ransohoff, Richard M.
    PLOS ONE, 2011, 6 (05):
  • [50] Clinical characterisation of interferon inhibitory activity in multiple sclerosis patients treated with IFN-β-1a
    Weinstock-Guttman, B.
    Ramanathan, M.
    Zivadinov, R.
    Khan, A.
    Dillon, M.
    Patrick, K.
    Masud, M. W.
    Hojnacki, D.
    Chadha, K.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 : 501 - 502
12345